Steven Hoerter is President and Chief Executive Officer of Deciphera Pharmaceuticals, Inc. (DCPH). The company reported total compensation of $6,010,712 for fiscal year 2023.
| Salary | $738,200 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,935,000 |
| Option awards | $2,837,100 |
| Non-equity incentive plan | $487,212 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $13,200 |
| Total | $6,010,712 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Deciphera Pharmaceuticals, Inc. filed April 25, 2024, accession 0001654151-24-000012.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2023 | President and Chief Executive Officer | $738,200 | $0 | $1,935,000 | $2,837,100 | $487,212 | $0 | $13,200 | $6,010,712 |
| FY2022 | President and Chief Executive Officer | $703,040 | $0 | $0 | $2,311,965 | $527,280 | $0 | $12,200 | $3,554,485 |
| FY2021 | President and Chief Executive Officer | $676,000 | $0 | $0 | $8,402,574 | $324,480 | $0 | $11,600 | $9,414,654 |
Totals as disclosed in each year's own compensation disclosure for Deciphera Pharmaceuticals, Inc..
| Peer-group chief executive median | $5,933,500 |
|---|---|
| Difference from that median | $77,212 |
| Percentile within the disclosed peer group | 55th |
| Peers with a disclosed figure | 11 |
Medians and percentiles are computed across the peer group Deciphera Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2023 total |
|---|---|---|
| Steven Hoerter this page | President and Chief Executive Officer | $6,010,712 |
| Dashyant Dhanak | Executive Vice President, Chief Scientific Officer | $3,063,207 |
| Matthew Sherman | Executive Vice President, Chief Medical Officer | $2,128,911 |
| Thomas Kelly | Executive Vice President, Chief Financial Officer and Treasurer | $2,030,801 |
| Daniel Flynn | Founder and Former Executive Vice President, Chief Scientific Officer | $1,999,385 |
| Daniel Martin | Senior Vice President, Chief Commercial Officer | $1,578,908 |
The company's named executive officers for fiscal year 2023, and what it reported for each. See the full Deciphera Pharmaceuticals, Inc. compensation brief.
Steven Hoerter's compensation sits inside Deciphera Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Deciphera Pharmaceuticals, Inc. (DCPH) compensation brief